首页>
外国专利>
APPLICATION OF PEG-INTERFERON AND PROTOONCOGENE PRODUCT TARGETING INHIBITOR IN SYNERGISTIC INHIBITION OF TUMORS
APPLICATION OF PEG-INTERFERON AND PROTOONCOGENE PRODUCT TARGETING INHIBITOR IN SYNERGISTIC INHIBITION OF TUMORS
展开▼
机译:PEG-干扰素和原虫基因烯产物靶向抑制剂在肿瘤协同抑制中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
An application of PEG-interferon and a protooncogene product targeting inhibitor in synergistic inhibition of tumors. Specifically, provided is use of an active ingredient combination. The active ingredient combination comprises PEG-interferon and a protooncogene product targeting inhibitor, and the combination is used for preparing a pharmaceutical composition for synergistic treatment of tumors. The active ingredient combination can synergistically inhibit the growth of tumors (especially lung, stomach, breast and liver cancers) effectively, and can significantly reduce toxic and side effects, and therefore can be widely used in targeted therapy of the tumors.
展开▼